QBL, QUEENSLAND BAUXITE LIMITED

[nipper]

some journo giving a 'heads up'

Australia currently has 16 marijuana companies on its sharemarket, with one of the most prominent being Cann Group, which has a market capitalisation of $296.98 million.

It's joined in the sector by AusCann, which has a market cap of $173.67 million.

Now, ASX minnow Queensland Bauxite, which — go figure, currently specialises in bauxite — on Thursday proposed to hold a September 14 meeting seeking shareholder approval to buy three pot companies and change its name. The new, proposed name? Cann Global.

As if it wasn't all confusing enough. And they say weed makes people more creative

https://www.afr.com/brand/rear-window/good-...20180819-h1464a

[blacksheep]

In Reply To: blacksheep's post @ Aug 1 2018, 02:43 PM

Another groundbreaking discovery announcement from QBL - no doubt they hope it will help them with their recently announced discounted CR, when they get out of suspension.

Seems no one - HC posters, HC company rep and QBL management - can understand why ASX did not mark the announcement "Price Sensitive" - Hello, the stock is suspended/cannot be traded. There is no need. Surely management know that?

The news is certainly Price Sensitive in nature, but management do not know why the ASX classified it as Non-price Sensitive.

[blacksheep]

In Reply To: blacksheep's post @ Jul 16 2018, 11:43 AM

This stock is always entertaining

- you can say that again. First it gets suspended for failing to release it's June Quarterly Report on time, and announces it's discounted the CR from 8c (almost double what the SP was at the time) to 3.5c. The ann was the reason the SP spiked to a high of 6.6c. Should be entertaining on HC with the Q&A between shareholders and the company rep

Further to the Transformation Announcement made on 20 June 2018, the Board of
Queensland Bauxite Limited (ASX: QBL or “the Company”) has recognised that due to current
market conditions, the intended capital raise at 8c is no longer an immediate practical option.
As a result, the Board has decided to amend the raising price for the recompliance.

The Board has decided that the revised offer under the recompliance will be a discounted
raising exclusively to shareholders of QBL, and as previously advised, the directors intend to
utilise their discretion to allocate the raising to shareholders in accordance with the size of
their shareholding and the length of time the shareholder has held their shares. The offer will
be open to all shareholders, and the directors will try to accommodate as many shareholders
as possible pro rata to their shareholding.

The Board has determined that the exclusive offer will be for a minimum raising of $2M and
an oversubscription up to a maximum raising of $6M, at 3.5c per share and one attaching 18
month option at 10c exercise price for every two shares subscribed for.

The Board also wishes to advise, that the Company has come to an agreement with Medcan
to extend the date for completion of the Medcan acquisition agreement to the 31st October
2018.

Attached thumbnail(s)

 

[blacksheep]

In Reply To: blacksheep's post @ Jul 3 2018, 03:03 PM

This stock is always entertaining
QBL’s acquisition target outed for recruiting American with drugs charges
4 hours ago | Rachel Williamson

Queensland Bauxite’s new acquisition target MedCan Australia may have hit a roadblock, after social media users pointed out strong similarities between a potential new employee and a man who was reportedly charged with drugs and weapons offences in the US.

MedCan is looking to hire an American for their grow operations.

After MedCan posted the man’s photo to its Facebook page on Thursday, investors pointed out the physical similarities with a man who had been arrested in South Carolina in 2013. The photo has since been deleted.

MedCan director Craig Cochrane told Stockhead they are still carrying out background checks on the potential hire.

Queensland Bauxite (ASX:QBL) director Shalom Feldman said to the best of their knowledge the charges were dropped.

“Every person is entitled to be given a fair go. If charges were never laid and if something like that never happened then that shouldn’t be something that should disqualify him from ever working again,” he told Stockhead.

The federal government’s Office of Drug Control has strict guidelines for who can work in medical cannabis companies, and says “A person is considered unsuitable if they:… for a period of 5 years prior to the application, have a history of illicit drug use or had a conviction for an illicit drug related offence.”

https://stockhead.com.au/health/qbls-acquis...-drugs-charges/

Attached thumbnail(s)

 

[blacksheep]

In Reply To: blacksheep's post @ Jul 2 2018, 04:30 PM

QBL's Company rep's latest post - looks like QBL can recommend "closing down" discussion How many other companies being discussed on HC have the same arrangements? Will QBL also monitor spamming ramps and close them down? Never seen this before

DEALING WITH THE QUESTIONS ON THIS FORUM

Good afternoon guys,

As many of you have now read the letter from the Managing Director to this forum, and through discussions with the HC administration, I have been given authority by the Board of QBL to deal with many of the questions that have been placed on this forum.

I am now no longer just restricted to Q & A's from PS announcements. The company has a responsibility to its shareholders and investors and we have begun a Media campaign to counter many of the posts which we believe, through the many emails and phone calls the Company has received, have led to many assumptions and rumours being falsely disseminated throughout Social media. The Company strongly believes the ruminations and the campaign of misinformation against the Company have had both a deleterious effect on investor sentiment towards our stock and our Board and management team. The rumours and spamming posts which are presently across much of the SM network, that question the company’s ability to conduct and run a successful business, are currently being dealt with by the company’s legal team.

Today, on this forum, we will be reopening the Q & A threads, as was agreed to in February with the HC administration team, we will set the guidelines in how these are to run in co-operation with HC administration, and as has been mentioned before, if these threads are abused we have been given permission (Feb/March) to recommend that the thread be closed to reduce spamming and help all members track our answer posts more effectively, which deal specifically with information relating to the Company, and will be of assistance to this forum.

As mentioned, in the letter from our Managing Director, Sholom Feldman, to this forum yesterday, there will be certain questions that cannot be answered on this forum and can only be answered through Announcements on the ASX platform. We will be monitoring closely those posts that continually spam and challenge our legal responsibility in how we report information on a Public platform. We will not be providing any information that could potentially be in breach of our reporting obligations on the ASX. To protect our company, its assets and in particular, our shareholders, we have a legal team to help us deal with these issues directly.

We now look forward to being more pro-active in the HC debate to assist our shareholders, investors and interested parties. We are sorry that we could not respond more pro-actively in the past, to manage the spamming and posts that were potentially misleading our shareholders and interested parties, and as seen in some posts recently, were causing some of our shareholders to doubt their investments.

We believe that the management of QBL and MCL have achieved significant accomplishments in the past year which speak for themselves, and should continue to provide our shareholders with the confidence for the future, and we will seek to clarify on this forum any issues relating to the current business of the company and its future direction to continue to assist our shareholders and prospective shareholders understand the company's business plans and direction.

Thanks.

Neil1959
HC QBL Authorized Rep
QUEENSLAND BAUXITE LIMITED

[blacksheep]

In Reply To: blacksheep's post @ Jun 21 2018, 12:35 PM

How odd ->
OPEN LETTER
from the Executive Chairperson, Mrs Pnina Feldman
MONDAY JULY 2 2018

extract

It is obvious by the many genuine questions and observations from shareholders to Queensland Bauxite ( ASX: QBL,
the “Company”), that although six weeks was spent both by the company and ASX to make sure that the company
merger/re-compliance announcement informed shareholders to the maximum, nevertheless there are still questions arising
from the lengthy announcement which some shareholders feel need to be addressed.

The company aims to comprehensively address these topics and queries in forthcoming announcements to assist
shareholders, especially those not familiar with complex corporate strategy and requirements, or those who wish to further
understand the strategy in place by the directors and management of the QBL Group, which includes the agreed acquisitions of
MCL (Medical Cannabis Ltd), and Medcan Australia.

QBL already appear to have a "Company Rep" who regularly gathers questions from posters, then seeks answers from QBL management, these answers are subsequently posted on HC.

IMHO - management - just get the job done, update the market and stop pandering to HC

Attached thumbnail(s)

 

[blacksheep]

In Reply To: blacksheep's post @ Jun 20 2018, 01:19 PM

We hope that our shareholders will share our excitement about these significant acquisitions and milestones

Shareholders are not looking all that excited ATM - SP up 16.33% currently @ 5.7c Perhaps it's the the huge amount of extra shares being offered for these acquisitions. Good luck with the CR @ 8c also

PART ONE - THE ACQUISITION OF 100% OF MEDCAN AUSTRALIA PTY LTD BY QBL

- Consideration: The consideration payable to the Vendors for the acquisition of their Medcan shares and units in the Trust will be satisfied through the issue of 250 million QBL shares, in proportion to their share and unit holdings. Upon completion of the acquisition, and the Company's proposed acquisition of MCL, this will represent an approximate 8% shareholding in the final merged entity (see part two of this announcement for further detail).

Not seeing a great deal of information on their webiste - https://medcanaustralia.com.au/

PART TWO - QBL ACQUIRES 100% OF MEDICAL CANNABIS LIMITEDTHE MERGER OF MCL AND QBL
Acquisition of MCL

- Consideration: The consideration payable to MCL Shareholders for their MCL shares is a total of 1,195,000,000 QBL shares. The value of the consideration payable has been determined by the parties to the MCL HOA with reference to the value attributed to MCL through QBL's trading price.

Capital raising
To assist the Company to re-comply with Chapters 1 and 2 of the Listing Rules and support the Medcan and MCL acquisition costs, the Company plans, subject to the approval of the Company's shareholders, to conduct a capital raising under a prospectus to raise up to $5 million, at a price of 8 cents per share.

[blacksheep]

This company must take out the "most frequent/lengthy suspension" award on the ASX - where's Pierpoint when you need him?. On this occasion it's taken well over a month to get approval from ASX to make this announcement which will now be released tomorrow. Better be a good one to "excite" the group of disgruntled holders who were calling for an EGM

QBL to Recommence Trading on Thursday 21st June

The Board of Queensland Bauxite Limited (ASX: QBL or “the Company”) is
delighted to announce that the ASX has approved the Company’s Announcement
to be released. The Company intends to release the announcement on Thursday
21 June 2018. QBL will recommence trading on the ASX following the release of
the Announcement.

The Board would like to thank our shareholders for their patience and support
during this process. The Board also appreciates the guidance and assistance
given to the Company during this period by the ASX.

We hope that our shareholders will share our excitement about these significant
acquisitions and milestones for our Company that the upcoming Announcement
will present.

The Board looks forward to QBL recommencing trading on the ASX platform.

[blacksheep]

In Reply To: blacksheep's post @ Jan 9 2018, 09:42 AM

Queensland Bauxite’s cannabis arm is planning to import the Panadol of cannabis – a pill they say you’ll one day be able to get with a simple prescription.

CannTab makes five different pills with different levels of THC and cannabinoids (CBD) and are designed for “everyday… medical purposes”.

“No doctor in the world is writing down a prescription [that] the patient takes away and goes to a chemist and gets their product,” Medical Cannabis founder Stephen Kasavilas told Stockhead.

He says currently doctors recommend products and then health departments decided whether or not you get to use it.

But that dream of prescription access is at least five to 10 years away: clinical trials in Australia will have to happen first and Therapeutic Goods Association (TGA) approval.

Right now they will only be allowed to sell through the same processes as all other companies in Australia: the Special Access Schemes and via Authorised Prescribers.

https://stockhead.com.au/health/cannabis-mi...marijuana-pill/

Attached thumbnail(s)

 

[blacksheep]

In Reply To: mme's post @ Jan 9 2018, 08:57 AM

Crazy, potty market behaviour. Of all the pot companies on the ASX this is the last one I would invest in - just my humble opinion. Hope it works out long term for punters Short term, day traders are smok'n it